Replies to post #659 on Lipocine Inc (LPCN)

[gi197845]

It would at least be nice, to soon have Tlando FDA approved, even if it's approved with Clarus still having exclusivity rights until March 2022.

This tentative approval of Tlando is another garbage delay...

I think Lipocine has a good chance of winning their patent dispute against Clarus in court.

However, I know litigation is delayed, due to Covid being used as an excuse.

I also know, that if Lipocine wins in court, that Clarus will appeal many times and the FDA will drag their feet on giving Tlando full approval, with the exclusivity rights being removed from Clarus and those rights being given over to their rightful owner, Tlando.

In my opinion, Clarus should have never received FDA approval.

Hopefully, the phase II NASH results will be excellent and will be announced in January.

It would be even better if the NASH results were so good, that a phase III is not required and the drug can be brought to market for the treatment of NASH much sooner.